AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17604332
Drug: Ketorolac Bier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac Bier block (6 mg of ketorolac tromethamine in saline)
Trial: 7208541
Drug: 350 mg
RxNorm normalized name: hemin 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg pivampicillin 3-times a day
Trial: 28784120
Drug: Commonly prescribed
RxNorm normalized name: Common carp
DrugBank: Common carp (DB10614)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commonly prescribed antihypertensive medication
Trial: 19450037
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy plus hypnosis (CBTH) in addition to standard medical care (SMC) (n = 22)
Trial: 15000763
Drug: Oralin spray
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oralin spray (100 U)
Trial: 15000763
Drug: OHAs (metformin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHAs (metformin + glyburide)
Trial: 28445231
Drug: Multi-Day Dosing
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-Day Dosing Group (n = 14)
Trial: 28445231
Drug: Single Pre-Exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single Pre-Exercise Dosing Group (n = 15)
Trial: 22384612
Drug: Standard doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard doses of hMG (control group)
Trial: 11122888
Drug: Increased dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased dose intensity during induction therapy
Trial: 11122888
Drug: Purged autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purged autologous bone marrow transplantation and standard chemotherapy consolidation
Trial: 11122888
Drug: Autologous transplantation
RxNorm normalized name: Washed Microbiota Transplantation
DrugBank: Washed Microbiota Transplantation (DB15745)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous transplantation and chemotherapy
Trial: 3571768
Drug: Bitolterol mesylate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitolterol mesylate, 1.0 mg, administered three times daily for 3 months
Trial: 3571768
Drug: Isoproterenol hydrochloride,
RxNorm normalized name: Isoproterenol Hydrochloride, 0.25% inhalation solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol hydrochloride, 1.5 mg, administered three times daily for 3 months
Trial: 18302679
Drug: 2% minocycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% minocycline hydrochloride ointment applied once into the pocket
Trial: 10761820
Drug: Other antipsychotic
RxNorm normalized name: Other antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antipsychotic drugs
Trial: 8872633
Drug: Thiorphan (inhaled,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiorphan (inhaled, 0.5 ml containing 1.25 mg/ml, administered by two inhalations)
Trial: 20452781
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea ingestion (3 breakfast cups, 540 ml total)
Trial: 19090602
Drug: Viscous fiber
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viscous fiber blend biscuits (10 g of highly viscous fiber blend)
Trial: 19090602
Drug: Control biscuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control biscuits (50 g available carbohydrates)
Trial: 19090602
Drug: White bread
RxNorm normalized name: White bread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White bread with 12 g of margarine
Trial: 2068950
Drug: Prednisone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (10 mg)
Trial: 2068950
Drug: 1,25-dihydroxyvitamin D3
RxNorm normalized name: 1,25-dihydroxyvitamin D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-dihydroxyvitamin D3 (2 micrograms) + Prednisone (10 mg)
Trial: 6631978
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of sexual awareness, relaxation and breathing (SARB group)
Trial: 27373438
Drug: CHF6001 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF6001 400 μg
Trial: 27373438
Drug: CHF6001 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHF6001 1200 μg
Trial: 11195234
Drug: Low-dose cisapride
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cisapride (0.1 mg/kg given 8 hourly)
Trial: 9124832
Drug: Daily primaquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily primaquine (0.5 mg of base per kg of body weight per day)
Trial: 9124832
Drug: Weekly chloroquine
RxNorm normalized name: Chloroquine
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly chloroquine (300 mg of base one time per week)
Trial: 1559542
Drug: rhGM-CSF (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGM-CSF (8 micrograms kg‐1) via intravenous (i.v.) bolus injection
Trial: 1559542
Drug: rhGM-CSF (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhGM-CSF (8 micrograms kg‐1) via subcutaneous (s.c.) bolus injection
Trial: 3888863
Drug: Pre-trial medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-trial medication
Trial: 26605752
Drug: Existing medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Existing medication guide prior to clinic visit (arm 1)
Trial: 22158529
Drug: Nebulised bronchodilator
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised bronchodilator therapy driven by oxygen
Trial: 22158529
Drug: Nebulised bronchodilator
RxNorm normalized name: Bronchodil
DrugBank: Reproterol (DB12846)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised bronchodilator therapy driven by air
Trial: 15741029
Drug: Intra‐oral distraction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra‐oral distraction devices
Trial: 15741029
Drug: Extra‐oral distraction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra‐oral distraction devices
Trial: 10332685
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (injected immediately before the meal)
Trial: 10332685
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (injected 30 min before the meal)
Trial: 31492152
Drug: TAC monotherapy
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TAC monotherapy (n = 20)
Trial: 24901809
Drug: 4.5 mg
RxNorm normalized name: phenol 14.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 mg · kg⁻¹ of caffeine
Trial: 24901809
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg of caffeine per kg of body weight)
Trial: 21602751
Drug: Propofol 6
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 6 mg kg h(‐1) (Group P, N=20)
Trial: 16142862
Drug: Intraarticular (IA)
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular (IA) triamcinolone hexacetonide injection
Trial: 16142862
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) triamcinolone acetonide mini-pulse therapy
Trial: 10535229
Drug: Preparing for
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparing for the Drug‐Free Years program (PDFY)
Trial: 7572244
Drug: Self-control therapy
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-control therapy program
Trial: 2338632
Drug: SR-verapamil fasting
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR-verapamil fasting (1 X 240 mg)
Trial: 2338632
Drug: SR-verapamil with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR-verapamil with food (1 X 240 mg)
Trial: 2338632
Drug: Conventional formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional formulation of verapamil fasting (3 X 80 mg)
Trial: 7448345
Drug: Quinidine formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine formulation 3
Trial: 30423463
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (15 x 300 mg capsules per day for 12 weeks)
Trial: 23493643
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate (234 mg on day 1, 156 mg on day 8, then once-monthly flexible dosing)
Trial: 23493643
Drug: Risperidone long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone long-acting injectable (RLAI) (25-50 mg biweekly, with oral risperidone supplementation on days 1-28)
Trial: 21627523
Drug: Polysulfated glycosaminoglycan
RxNorm normalized name: polysulfated glycosaminoglycan
DrugBank: Polysulfated glycosaminoglycan (DB11538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polysulfated glycosaminoglycan treatment (PSGAGT)
Trial: 19862981
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with target INR of 1.50 to 1.99 (Group A)
Trial: 19862981
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with target INR of 2.00 to 2.50 (Group B)
Trial: 19862981
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with target INR of 2.51 to 3.00 (Group C)
Trial: 19862981
Drug: Warfarin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin with target INR of 1.50 to 2.50 (Group A and B)
Trial: 15169803
Drug: TAP (doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP (doxorubicin 45 mg/m(2), cisplatin 50 mg/m(2), paclitaxel 160 mg/m(2) with filgrastim)
Trial: 15169803
Drug: AP (doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AP (doxorubicin 60 mg/m(2), cisplatin 50 mg/m(2))
Trial: 8489566
Drug: Immediate release
RxNorm normalized name: Namenda, immediate release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate release bezafibrate 300 mg dragee (A)
Trial: 8489566
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release bezafibrate 400 mg dragee (B)
Trial: 3318368
Drug: Mexiletine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mexiletine (200 to 400 mg every 8 hours)
Trial: 3318368
Drug: Quinidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine (200 to 400 mg every 6 hours)
Trial: 27162173
Drug: ASP015K (peficitinib)
RxNorm normalized name: peficitinib
DrugBank: Peficitinib (DB11708)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: ASP015K (peficitinib) 3 mg to 300 mg single dose
Trial: 27162173
Drug: ASP015K (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASP015K (30 mg) multiple doses
Trial: 24998109
Drug: Fibrinogen concentrate
RxNorm normalized name: Fibrinogen concentrate human
DrugBank: Fibrinogen human (DB09222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinogen concentrate (1g administered 30 min prior to operation)
Trial: 22649162
Drug: Cognitive Sensory
RxNorm normalized name: SENSORY ORGANS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Sensory Motor Training Therapy (Perfetti's method)
Trial: 10189646
Drug: 2% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% lidocaine with 1:100,000 epinephrine diluted 1:9 with 0.9% bacteriostatic saline solution
Trial: 25146009
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 3% mepivacaine plus 2% lidocaine with 1:100,000 epinephrine
Trial: 25146009
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2% lidocaine with 1:100,000 epinephrine plus 2% lidocaine with 1:100,000 epinephrine
Trial: 22545190
Drug: SURG+systemic amoxicillin+systemic
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SURG+systemic amoxicillin+systemic metronidazole
Trial: 15981555
Drug: Nebivolol (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (target dose 5 mg)
Trial: 10606909
Drug: Intraportal infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraportal infusion of lymphokine‐activated killer (LAK) cells combined with recombinant interleukin 2 (rIL‐2)
Trial: 10606909
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (resection, IORT and LAK cells with rIL-2)
Trial: 1734247
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (1 g per day for 3 days, followed by oral prednisone 1 mg/kg/day for 11 days)
Trial: 1734247
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone (1 mg/kg/day for 14 days)
Trial: 26786575
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy group (74% experienced serious hypoglycemia)
Trial: 26786575
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment group (21% experienced serious hypoglycemia)
Trial: 20236094
Drug: Diphenhydramine 25
RxNorm normalized name: DIPHENHYDRAMINE 25MG CHEW TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 25 mg i.v.
Trial: 18519309
Drug: Nonoperative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonoperative treatment with a cast
Trial: 16042226
Drug: IVIG (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (1 g/kg body weight monthly for 27 months)
Trial: 16042226
Drug: Placebo (albumin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (albumin 0.1% monthly for 27 months)
Trial: 8949805
Drug: Rocuronium 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.6 mg kg‐1 (2xED95)
Trial: 8949805
Drug: Rocuronium 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 0.9 mg kg‐1 (3xED95)
Trial: 29157034
Drug: Pregabalin plus
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin plus IV ibuprofen (150 mg pregabalin and 400 mg IV ibuprofen)
Trial: 15182276
Drug: BUD +
RxNorm normalized name: Clove buds
DrugBank: Clove (DB10672)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUD + M group (400 microg/day of inhaled budesonide plus 10 mg/day of montelukast)
Trial: 15182276
Drug: High BUD
RxNorm normalized name: Clove buds
DrugBank: Clove (DB10672)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High BUD group (800 microg/day of inhaled budesonide)
Trial: 3302251
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (multivitamin/multimineral) at high and low dosage
Trial: 31665732
Drug: High-frequency repetitive
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-frequency repetitive transcranial magnetic stimulation (rTMS) targeting the left dorsolateral prefrontal cortex, 15 Hz, twice daily, 5 days/week for 2 weeks
Trial: 21858663
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (tamsulosin + potassium citrate)
Trial: 15477693
Drug: Intramuscular octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular octreotide LAR (20 mg initially, increased to 30 mg after 3 injections if mean GH levels >5 mU/l) administered every 28 days for 6 months
Trial: 15477693
Drug: Subcutaneous octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous octreotide (50, 100 and 200 mug) administered in a randomized order on separate days prior to LAR therapy
Trial: 15477693
Drug: Intramuscular octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular octreotide LAR
Trial: 7884757
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g of a glucose polymer
Trial: 25656621
Drug: Maraviroc 150
RxNorm normalized name: maraviroc 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maraviroc 150 mg daily plus lopinavir/ritonavir (MVC group)
Trial: 18211302
Drug: Venlafaxine 75
RxNorm normalized name: venlafaxine 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 75 mg extended release
Trial: 10735921
Drug: omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 20 mg at 08:00 hours for 14 days
Trial: 10735921
Drug: ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 300 mg at 22:00 hours for 14 days
Trial: 4034850
Drug: Naloxone hydrochloride
RxNorm normalized name: Naloxone Hydrochloride
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naloxone hydrochloride (2 mg intravenous bolus)
Trial: 4034850
Drug: Naloxone hydrochloride
RxNorm normalized name: Naloxone Hydrochloride
DrugBank: Naloxone (DB01183)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naloxone hydrochloride (2 mg intravenous bolus) with estrogen (intramuscular 17-beta-estradiol)
Trial: 23906186
Drug: Dexmedetomidine (DEX)
DrugBank: Dexmedetomidine (DB00633)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexmedetomidine (DEX) at a dose of 1.0 μg/kg over 10 min followed by a continuous infusion of 0.5 μg/kg per hour
Trial: 23906186
Drug: Sufentanil (SUF)
DrugBank: Sufentanil (DB00708)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sufentanil (SUF) target controlled infusion with a target plasma concentration of 0.3 ng/mL
Trial: 12154100
Drug: Eplerenone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eplerenone (50 mg, increasing to 100 mg if required) once daily for 8 weeks
Trial: 7884097
Drug: Oral pirenzepine
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pirenzepine (25 mg twice daily)
Trial: 2104624
Drug: Dexamethasone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (4 mg, iv)
Trial: 2104624
Drug: Dexamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (8 mg, orally)
Trial: 2104624
Drug: Dexamethasone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (4 mg, iv) + Placebo
Trial: 2104624
Drug: Dexamethasone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (4 mg, iv) + Atropine (0.5 mg, iv)
Trial: 2104624
Drug: Dexamethasone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (4 mg, iv) + Pyridostigmine (120 mg, orally)
Trial: 356578
Drug: Intramuscular lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular lidocaine (300 mg)
Trial: 30904515
Drug: Real injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
DrugBank: Carboxymethylcellulose (DB11059)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real injection (hypertonic saline)
Trial: 30904515
Drug: Sham injection
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham injection (no skin piercing)
Trial: 28236348
Drug: Fixed time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed time interval administration of tramadol, paracetamol, and diclofenac
Trial: 28236348
Drug: On-demand administration
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-demand administration of tramadol, paracetamol, and diclofenac
Trial: 15041715
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel (35 mg/m(2))
Trial: 15041715
Drug: 3-weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly docetaxel (60 mg/m(2) with doxorubicin)
Trial: 15041715
Drug: 3-weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly docetaxel (75 mg/m(2))
Trial: 15041715
Drug: 3-weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-weekly docetaxel (100 mg/m(2))
Trial: 11106052
Drug: Intravenous ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ibuprofen lysine (10 mg/kg, followed by 5 mg/kg after 24 and 48 h) within 24 h of life (group A)
Trial: 11106052
Drug: Intravenous ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous ibuprofen lysine (10 mg/kg, followed by 5 mg/kg after 24 and 48 h) after echocardiographic diagnosis of PDA (group B)
Trial: 8358406
Drug: methylphenidate (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylphenidate (0.3 mg/kg b.i.d.)